Peginterferon
Drug Details
- Description
- Peginterferon is a long-acting form of interferon used to treat chronic hepatitis C and some forms of multiple sclerosis. It is a pegylated form, meaning it has been chemically modified with polyethylene glycol to improve its stability and prolong its action in the body.
- Alternative Names
- Peginterferon.
- Key Genes
- Key genes involved with peginterferon treatment include IFNL3 (IL28B), which is associated with treatment response for hepatitis C, and IFNAR1/2, involved in the interferon signaling pathway.
- Drug Use
- Peginterferon is used to treat hepatitis C, hepatitis B, and certain types of cancer, such as melanoma. It helps to reduce viral load and control the progression of these diseases.
- Genetic Factors Influencing Response
-
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Lorem ipsum dolor sit amet, consectetur adipiscing elit.
Purchase Membership to Access Your Individual Drug Response Report